SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-040866
Filing Date
2024-03-29
Accepted
2024-03-29 08:30:50
Documents
5
Period of Report
2024-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2410083d1_6k.htm 6-K 14362
2 EXHIBIT 99.1 tm2410083d1_ex99-1.htm EX-99.1 64258
3 EXHIBIT 99.2 tm2410083d1_ex99-2.htm EX-99.2 68394
4 GRAPHIC tm2410083d1_ex99-2img001.jpg GRAPHIC 1999
5 GRAPHIC tm2410083d1_ex99-1img01.jpg GRAPHIC 4943
  Complete submission text file 0001104659-24-040866.txt   157950
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 24802115
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)